The novel chemical strategy for sustainability calls for a Sustainable and Safe-by-Design (SSbD) holistic approach to achieve protection of public health and the environment, industrial relevance, societal empowerment, and regulatory preparedness. Based on it, the ASINA project expands a data-driven Management Methodology (ASINA-SMM) capturing quality, safety, and sustainability criteria across the Nano-Enabled Products’ (NEPs) life cycle. We base the development of this methodology through value chains of highly representative classes of NEPs in the market, namely, (i) self-cleaning/air-purifying/antimicrobial coatings and (ii) nano-structured capsules delivering active phases in cosmetics. These NEPs improve environmental quality and human health/wellness and have innovative competence to industrial sectors such as healthcare, textiles, cosmetics, and medical devices. The purpose of this article is to visually exhibit and explain the ASINA approach, which allows identifying, combining, and addressing the following pillars: environmental impact, techno-economic performance, functionality, and human and environmental safety when developing novel NEPs, at an early stage. A metamodel supports the above by utilizing quality data collected throughout the NEPs’ life cycle, for maximization of functionality (to meet stakeholders needs) and nano-safety (regulatory obligations) and for the minimization of costs (to meet business requirements) and environmental impacts (to achieve sustainability). Furthermore, ASINA explores digitalization opportunities (digital twins) to speed the nano-industry translation into automatic progress towards economic, social, environmental, and governance sustainability.
The present work reports the thermodynamic study performed on three monofluorinated nitrobenzene derivatives by a combination of experimental techniques and computational approaches. The standard (p degrees = 0.1 MPa) molar enthalpies of formation in the liquid phase of the three isomers of fluoronitrobenzene were derived from the standard molar energies of combustion, in oxygen, at T = 298.15 K, measured by rotating bomb combustion calorimetry. The vapor pressure study of the referred compounds was done by a static method and, from the obtained results, the phase diagrams were elaborated, and the respective triple point coordinates, as well as the standard molar enthalpies of vaporization, sublimation and fusion, at T = 298.15 K, were determined. The combination of some of the referred thermodynamic parameters yielded the standard (p degrees = 0.1 MPa) molar enthalpies of formation in the gaseous phase, at T = 298.15 K, of the studied compounds: Delta(f)H(m)(o) (2-fluoronitrobenzene, g) = -(102.4 +/- 1.5) kJ x mol(-1), Delta(f)H(m)(o) (3-fluoronitrobenzene, g) = -(128.0 +/- 1.7) kJ x mol(-1), and Delta(f)H(m)(o) (4-fluoronitrobenzene, g) = -(133.9 +/- 1.4) kJ x mol(-1). Using the empirical scheme developed by Cox, values of standard molar enthalpies of formation in the gaseous phase were estimated and afterwards compared with the ones obtained experimentally, and both were interpreted in terms of the molecular structure of the compounds. The theoretically estimated gas-phase enthalpies of formation were calculated from high-level ab initio molecular orbital calculations at the G3(MP2)//B3LYP level of theory. The computed values compare very well with the experimental results obtained in this work and show that 4-fluoronitrobenzene is the most stable isomer from the thermodynamic point of view. Furthermore, this composite approach was also used to obtain information about the gas-phase basicities, proton and electron affinities and, finally, adiabatic ionization enthalpies.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.